Research Worth Sharing, March 2024 Edition
Organ-specific aging, a blood-based test for brain tumors, avoiding bananas in smoothies, stair-climbing tests for frailty, and omega-3 intake and CVD
Research Worth Sharing, December 2023 Edition
MDMA for PTSD, the HALL aging database, peanut immunotherapy, blood pressure cuff sizes and accuracy, and the effects of swearing on strength
Understanding the Relationship Between Body Composition and Mortality Using Artificial Intelligence (AI)
For predicting health outcomes, more information means more accuracy
#266 – AMA #50: Genetics: how they impact disease risk, what you can do about it, testing, and more
“With how much uncertainty there is in genetic testing, I just think everybody needs to be thoughtful about it before they do it.” —Peter Attia
How failures in study selection can sink a meta-analysis
Mixing apples and oranges and winding up with garbage
#249 ‒ How the brain works, Andrew’s fascinating backstory, improving scientific literacy, and more | Andrew Huberman, Ph.D.
“I want to communicate the beauty and utility of biology. I want to do that by being a teacher and a storyteller.” —Andrew Huberman
Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs”
Clinical trials have generated impressive data on the effects of GLP-1 agonists on body weight and BMI, but how do these drugs perform in terms of body composition?